Skip to main content

Table 1 Involving published articles after systematic retrieval

From: The roles of iodized oil-based lymphangiography and post-lymphangiographic computed tomography for specific lymphatic intervention planning in patients with postoperative lymphatic fistula: a literature review and case series

Year Author and reference Patient number Clinical presentation Performance of LAG and post-LAG CT Types of percutaneous intervention after LAG Guidance modality Agents Technical success Clinical success
2002 Cope C, et al. (Cope and Kaiser 2002) 42 Chylothorax TL TDE Fluoroscopy Coils, PVA, or NBCA. 89.6% 84.6%
TDD 21- or 22-gauge needle 43.8%
2005 Binkert CA, et al. (Binkert, Yucel et al. 2005) 8 Chylothorax TL TDE Fluoroscopy Coils + NBCA 100.0% 100.0%
TDD 21-gauge needle 100.0%
2008 Boffa DJ, et al. (Boffa et al. 2008) 37 Chylothorax TL TDE Fluoroscopy NBCA ± coils 57.1% 100.0%
TDD 22-gauge needle 66.7%
2010 Itkin M, et al. (Itkin et al. 2010) 109 Chylothorax/chylopericardium/cervical chylous fistula TL TDE Fluoroscopy NBCA or Onyx ± coils 67.0% 90.1%
TDD 21- or 22-gauge needle 72.2%
2014 Kortes N, et al. (Kortes et al. 2014) 18 Inguinal lymphocele/pelvic lymphocele/abdominal lymphatic leakage/chylothorax TL and post-LAG CT ALVS CT Ethanol 100.0% 77.8%
2016 Baek Y, et al. (Baek et al. 2016a) 5 Pelvic lymphocele INL ALVE Fluoroscopy NBCA 100.0% 75.0%
2016 Baek Y, et al. (Baek et al. 2016b) 21 Pelvic lymphatic leakage INL DLE Fluoroscopy NBCA 100.0% 85.0%
ALVE NBCA
TNE NBCA
2016 Hur S, et al. (Hur et al. 2016) 27 Chylothorax / chylous ascites/lymphoceles / skin fistula INL DLE Fluoroscopy / Cone-beam CT NBCA 89.3% 93.8%
ALVE NBCA
TNE NBCA
2017 Kariya S, et al. (Kariya, Nakatani et al. 2017) 5 Chylothorax INL TDE Fluoroscopy NBCA 100.0% 100.0%
2017 Yannes M, et al. (Yannes et al. 2017) 57 Chylothorax INL TDE Fluoroscopy / CT / Sonography NBCA + Coils 63.6% 90.5%
TDD 21- or 22-gauge needle 41.7%
2018 Majdalany BS, et al. (Majdalany et al. 2018) 11 Chylothorax INL TDE Fluoroscopy NBCA ± Coils 37.5% 100.0%
TDD 22-gauge needle 66.7%
2018 Nadolski GJ, et al. (Nadolski and Itkin 2018) 31 Refractory chylous ascites TL/INL DLE Fluoroscopy Coils + NBCA 100.0% 81.8%
TNE NBCA
2018 Nadolski GJ, et al. (Nadolski and Itkin 2018) 50 Chylothorax TL/INL TDE Fluoroscopy Coils + NBCA, NBCA, Onyx, or autologous blood. 98.0% 91.8%
TDD 21or 22-gauge needle 0.0%
2018 Reisenauer JS, et al. (Reisenauer et al. 2018) 97 Chylothorax TL TDE Fluoroscopy Coils, NBCA, Onyx, or Gelfoam. 47.5% 78.9%
2018 Smolock AR, et al. (Smolock et al. 2018) 10 Inguinal lymphocele and lymphorrhea INL TNE Fluoroscopy NBCA 100.0% 80.0%
2018 Yildirim IO, et al. (Yildirim et al. 2018) 13 Pelvic lymphocele INL DLE Fluoroscopy / Cone-beam CT NBCA 100.0% 88.9%
2018 Chu HH, et al. (Chu et al. 2019) 9 Pelvic Lymphocele INL DLE Fluoroscopy NBCA 100.0% 100.0%
TNE NBCA
2019 Kim SW, et al. (Kim et al. 2019) 33 Pelvic lymphocele INL TNE Fluoroscopy / Sonography NBCA 100.0% 83.3%
DLS Ethanol 43.8%
  1. Abbreviation: ALVE Afferent lymphatic vessel embolization, ALVS Afferent lymphatic vessel sclerotherapy, DLE Direct leakage embolization, DLS Direct leakage sclerotherapy, INL Intranodal iodized oil-based lymphangiography, NBCA N-butyl cyanoacrylate, PVA Polyvinyl alcohol, post-LAG CT Post-lymphangiographic computed tomography, TDE Percutaneous thoracic duct embolization, TDD Percutaneous thoracic duct disruption, TL Trans-pedal iodized oil-based lymphangiography, TNE Trans-nodal embolization